Jay R. Luly, President and CEO at ENANTA PHARMACEUTICALS INC (ENTA), sold 50,000 shares at $105.82 ($5.3M) on 2018-05-16, disclosed to the SEC on 2018-05-18.
Open-market sale of $5.3M ENTA by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $105.82 | 14,032 | $1.5M | 28.1% |
| 2 | $105.82 | 14,032 | $1.5M | 28.1% |
| 3 | $105.83 | 10,968 | $1.2M | 21.9% |
| 4 | $105.83 | 10,968 | $1.2M | 21.9% |
| Total | $105.82 avg | 50,000 | $5.3M | 100% |
| Filing → |
| ENTA | SELL | 2024-12-10 | $41K | — | Filing → |
| ENTA | SELL | 2023-12-06 | $139K | — | Filing → |
| ENTA | SELL | 2023-03-14 | $2.5M | — | Filing → |